You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 11, November 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor

William R. Panje, MD

Arch Otolaryngol. 1981;107(11):658-663.


Abstract

• The in vivo administration of a prostaglandin-synthetase inhibitor inhibited or reduced tumor growth in cancer patients and experimental animals. Indomethacin, a prostaglandin-synthetase inhibitor and nonsteroidal anti-inflammatory agent commonly used in the management of arthritic patients, acted as an immune adjuvant by decreasing the production of prostaglandins. Seven cases demonstrated that indomethacin taken in the usually recommended dosages causes regression and stabilization of head and neck cancer. The following factors were also considered in this study: prostaglandin production, a survey of other reports of solid neoplasm response to prostaglandin-synthetase inhibitor administration, drug toxicity, irradiation therapy and metastases, the need for tumor biopsy, and the role that reduction in inflammation plays in tumor shrinkage.

(Arch Otolaryngol 1981;107:658-663)



Author Affiliations

From the Department of Otolaryngology and Maxillofacial Surgery, Division of Head and Neck Surgical Oncology, University of Iowa Hospitals, Iowa City.


Footnotes

Accepted for publication May 7, 1981.

Read before the combined meeting of the Society of Head and Neck Surgeons and the American Society for Head and Neck Surgery, Phoenix, Ariz, March 9, 1981.

Reprint requests to Department of Otolaryngology and Maxillofacial Surgery, University of Iowa Hospitals, Iowa City, IA 52242 (Dr Panje).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Elevated Levels of Urinary Prostaglandin E Metabolite Indicate a Poor Prognosis in Ever Smoker Head and Neck Squamous Cell Carcinoma Patients
Kekatpure et al.
Cancer Prevention Research 2009;2:957-965.
ABSTRACT | FULL TEXT  

Role of Cyclooxygenase-2 in Tumor Progression and Survival of Head and Neck Squamous Cell Carcinoma
Cancer Prevention Research 2009;2:823-829.
 

Polyvinyl Alcohol--Gelatin Patches of Salicylic Acid: Preparation, Characterization and Drug Release Studies
Pal et al.
J Biomater Appl 2006;21:75-91.
ABSTRACT  

The Cyclooxygenase 2-selective Inhibitor NS398 Inhibits Proliferation of Oral Carcinoma Cell Lines by Mechanisms Dependent and Independent of Reduced Prostaglandin E2 Synthesis
Minter et al.
Clin. Cancer Res. 2003;9:1885-1897.
ABSTRACT | FULL TEXT  

Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?
HONG et al.
FASEB J. 2000;14:1499-1507.
ABSTRACT | FULL TEXT  

An Open Study to Assess the Efficacy and Safety of Topical 3% Diclofenac in a 2.5% Hyaluronic Acid Gel for the Treatment of Actinic Keratoses
Rivers and McLean
Arch Dermatol 1997;133:1239-1242.
ABSTRACT  

Inhibition of Growth of a Murine Squamous Cell Carcinoma by a Cyclooxygenase Inhibitor Increases Leukotriene B4 Production
Snyderman et al.
Arch Otolaryngol Head Neck Surg 1995;121:1017-1020.
ABSTRACT  

Phospholipid Metabolite Expression by Head and Neck Squamous Cell Carcinoma
Mann et al.
Arch Otolaryngol Head Neck Surg 1994;120:763-769.
ABSTRACT  

Administration of a Prostaglandin Synthetase Inhibitor Associated With an Increased Immune Cell Infiltrate in Squamous Cell Carcinoma of the Head and Neck
Cross et al.
Arch Otolaryngol Head Neck Surg 1992;118:526-528.
ABSTRACT  

Prostaglandin Inhibitor and Radiotherapy in Advanced Head and Neck Cancers
Pillsbury et al.
Arch Otolaryngol Head Neck Surg 1986;112:552-553.
ABSTRACT  

Prostaglandins and Other Metabolites of Arachidonic Acid: An Overview for the Otolaryngologist
Poole and Pillsbury
Arch Otolaryngol Head Neck Surg 1985;111:317-321.
ABSTRACT  

The Effect of Indomethacin on the Growth of Epidermoid Carcinoma of the Palate in Rats
Blitzer and Huang
Arch Otolaryngol Head Neck Surg 1983;109:719-723.
ABSTRACT  

Immunostimulation of Patients With Head and Neck Cancer: In Vitro and Preliminary Clinical Experiences
Hirsch et al.
Arch Otolaryngol Head Neck Surg 1983;109:298-301.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.